During the past decade, Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie" #1 sponsor was "AVEO Pharmaceuticals, Inc." with 1 trials, followed by "Bayer" with 1 trials sponsored, "Fresenius Kabi" with 1 trials sponsored, "Galera Therapeutics, Inc." with 1 trials sponsored and "Genmab" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "IQVIA Commercial GmbH & Co. OHG" with 1 trials as a collaborator, "Parexel" with 1 trials as a collaborator, "Population Health Research Institute" with 1 trials as a collaborator and "Vanderbilt University Medical Center" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie" are "Head and Neck Cancer" (2 trials), "Myocardial Injury After Noncardiac Surgery (MINS)" (2 trials), "Critical Illness" (1 trials), "Gastric Cancer" (1 trials) and "Gastroesophageal Junction Cancer" (1 trials). Many other conditions were trialed in "Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie" in a lesser frequency.

Most popular intervention types in "Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie" are "Drug" (8 trials), "Other" (2 trials), "Biological" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Enoxaparin" (2 trials), "Placebo" (2 trials), "Apixaban" (1 trials), "BAY1213790" (1 trials) and "BBI608" (1 trials). Other intervention names were less common.

The vast majority of trials in "Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".